Reversal of pathological pain through specific spinal GABAA receptor subtypes
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Inflammatory diseases and neuropathic insults are frequently accompanied by severe and debilitating pain, which can become chronic and often unresponsive to conventional analgesic treatment. A loss of synaptic inhibition in the spinal dorsal horn is considered to contribute significantly to this pain pathology. Facilitation of spinal gamma-aminobutyric acid (GABA)ergic neurotransmission through modulation of GABA(A) receptors should be able to compensate for this loss. With the use of GABA(A)-receptor point-mutated knock-in mice in which specific GABA(A) receptor subtypes have been selectively rendered insensitive to benzodiazepine-site ligands, we show here that pronounced analgesia can be achieved by specifically targeting spinal GABA(A) receptors containing the alpha2 and/or alpha3 subunits. We show that their selective activation by the non-sedative ('alpha1-sparing') benzodiazepine-site ligand L-838,417 (ref. 13) is highly effective against inflammatory and neuropathic pain yet devoid of unwanted sedation, motor impairment and tolerance development. L-838,417 not only diminished the nociceptive input to the brain but also reduced the activity of brain areas related to the associative-emotional components of pain, as shown by functional magnetic resonance imaging in rats. These results provide a rational basis for the development of subtype-selective GABAergic drugs for the treatment of chronic pain, which is often refractory to classical analgesics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Also, in contrast to morphine, no analgesic tolerance occurred in rats after a 9-day treatment with the α 2/3 subtype GABAA receptor positive allosteric modulator L838,417 using a model of neuropathic pain [157].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [157]
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
The rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,831
Melzack, R., & Wall, P. D. (1965) · Science · doi:10.1126/science.150.3699.971 · Cited by 11,090
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man
Bennett, G. J., & Xie, Y.-K. (1988) · Pain · doi:10.1016/0304-3959(88)90209-6 · Cited by 5,376
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
Hargreaves, K., Dubner, R., Brown, F., Flores, C., & Joris, J. (1988) · Pain · doi:10.1016/0304-3959(88)90026-7 · Cited by 5,135
Neuronal plasticity: Increasing the gain in pain
Woolf, C. J., & Salter, M. W. (2000) · Science · doi:10.1126/science.288.5472.1765 · Cited by 3,781
Dubuisson, D., & Dennis, S. G. (1977) · Pain · doi:10.1016/0304-3959(77)90130-0 · Cited by 2,524
RARE imaging: A fast imaging method for clinical MR
Hennig, J., Nauerth, A., & Friedburg, H. (1986) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910030602 · Cited by 2,081
BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain
Coull, J. A. M., Beggs, S., Boudreau, D., Boivin, D., Tsuda, M., Inoue, K., Gravel, C., Salter, M. W., & De Koninck, Y. (2005) · Nature · doi:10.1038/nature04223 · Cited by 1,965
Cited by
Items 201–300 of 441
Insights into the Structure and Pharmacology of GABAAReceptors
Carter, C. R. J., Kozuska, J. L., & Dunn, S. M. J. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.178 · Cited by 35
Cell transplants to treat the “disease” of neuropathic pain and itch
Basbaum, A. I., & Braz, J. M. (2016) · Pain · doi:10.1097/j.pain.0000000000000441 · Cited by 28
“Of course, consistent with the hypothesis that loss of GABAergic inhibition is critical are studies reporting the normalization of pain thresholds by pharmacological restoration of GABAergic transmission.(28,37) Also of interest are approaches to long-term regulation using, for example, trigeminal injection of an aden…”
BackgroundRole of gabra2, GABAA receptor alpha-2 subunit, in CNS development
González-Núñez, V. (2015) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2015.08.003 · Cited by 37
Lack of positive allosteric modulation of mutated α1S267I glycine receptors by cannabinoids
Foadi, N., Leuwer, M., Demir, R., Dengler, R., Buchholz, V., de la Roche, J., Karst, M., Haeseler, G., & Ahrens, J. (2010) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-010-0506-9 · Cited by 29
“In recent years, loss of inhibitory synaptic transmission within the dorsal horn of the spinal cord has been established as one of the major mechanisms involved in the development of chronic pain following inflammation or nerve injury (Bolay andMoskowitz 2002; Betz and Laube 2006; Knabl et al. 2008).”
BackgroundPrimary afferent-driven presynaptic inhibition of C-fiber inputs to spinal lamina I neurons
Fernandes, E. C., Pechincha, C., Luz, L. L., Kókai, É., Szűcs, P., & Safronov, B. V. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101786 · Cited by 26
Modulation of Spinal GABAergic Analgesia by Inhibition of Chloride Extrusion Capacity in Mice
Asiedu, M. N., Mejia, G. L., Ossipov, M. K., Malan, T. P., Kaila, K., & Price, T. J. (2012) · Journal of Pain · doi:10.1016/j.jpain.2012.03.002 · Cited by 25
Herde, A. M., Benke, D., Ralvenius, W. T., Mu, L., Schibli, R., Zeilhofer, H. U., & Krämer, S. D. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.02.022 · Cited by 27
Self-citationNomura, T., Hawkins, N. A., Kearney, J. A., George, A. L., & Contractor, A. (2019) · The Journal of Physiology · doi:10.1113/jp277651 · Cited by 26
“These results demonstrate that the α2 / α3 selective PAM differentially modulates inhibitory synapses located in the perisomatic region of CA1 neurons.”
BackgroundMethodInfluentialObradović, A. L., Scarpa, J. R., Osuru, H. P., Weaver, J. L., Park, J.-Y., Pathirathna, S., Peterkin, A. L., Lim, Y. H., Jagodic, M. M., Todorovic, S. M., et al. (2015) · Anesthesiology · doi:10.1097/aln.0000000000000767 · Cited by 28
“We found statistically significant interaction between time and paw due to knockdown of the α2 subunit with ASODNs [F(11,44) = 11.”
BackgroundHeteromeric GABA A receptor structures in positively-modulated active statesPreprint
Miller, P. S., Masiulis, S., Malinauskas, T., Kotecha, A., Rao, S., Chavali, S., Colibus, L. D., Pardon, E., Hannan, S. B., Scott, S., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/338343 · Cited by 28
Dorsal horn circuitry: Complexity and implications for mechanisms of neuropathic pain
Benarroch, E. E. (2016) · Neurology · doi:10.1212/wnl.0000000000002478 · Cited by 31
Kanao-Kanda, M., Kanda, H., Liu, S., Roy, S., Toborek, M. J., & Hao, S. (2020) · Human Gene Therapy · doi:10.1089/hum.2019.359 · Cited by 23
“Primary input high-threshold C- and Ad-fibers transmitting pain signal project to the laminae I–II in the SCDH; low-threshold C-/Ad-fibers carrying touch signal project to lamina II inner and III.72,73 A-fibers transmit touch information through the dorsal columns to the brainstem as well as send collaterals into the…”
BackgroundSpinal astrocyte aldehyde dehydrogenase-2 mediates ethanol metabolism and analgesia in mice
Jin, S., Çınar, R., Hu, X., Lin, Y., Luo, G., Lovinger, D. M., Zhang, Y., & Zhang, L. (2021) · British Journal of Anaesthesia · doi:10.1016/j.bja.2021.02.035 · Cited by 22
Dieb, W., & Hafidi, A. (2014) · European Journal of Pain · doi:10.1002/ejp.525 · Cited by 25
Melin, C., Jacquot, F., Dallel, R., & Artola, A. (2012) · European Journal of Neuroscience · doi:10.1111/ejn.12048 · Cited by 28
“…2001; Seagrove et al., 2004; Miraucourt et al., 2007, 2009), bicuculline (i.c. 10 nmol compared with intrathecal 3–300 nmol: Sivilotti & Woolf, 1994; Kontinen et al., 2001), phaclofen (100 nmol compared with intrathecal 4–80 nmol: Malan et al., 2002; Gwak et al., 2006) and baclofen (0.007–0.7…”
BackgroundMethodInfluentialAssociation Study of GABAA α2 Receptor Subunit Gene Variants in Antipsychotic-Associated Weight Gain
Zai, C. C. H., Tiwari, A. K., Chowdhury, N. I., Brandl, E. J., Shaikh, S. A., Freeman, N., Lieberman, J. A., Meltzer, H. Y., Müller, D. J., & Kennedy, J. L. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000261 · Cited by 21
“It seems to be involved in the action of benzodiazepines in reducing response to pain stimuli in rodents.(27) The GABRA2 gene, in particular, has been implicated in alcohol dependence and conduct disorder,(16,17) and was one of the top findings in a recent genomewide meta-analysis of obesity,(18) making it an appealin…”
Backgroundα5GABAA receptors mediate primary afferent fiber tonic excitability in the turtle spinal cord
Loeza‐Alcocer, E., Canto-Bustos, M., Aguilar, J., González‐Ramírez, R., Felix, R., & Delgado‐Lezama, R. (2013) · Journal of Neurophysiology · doi:10.1152/jn.00330.2013 · Cited by 22
Reviewing the case for compromised spinal inhibition in neuropathic pain
Gradwell, M. A., Callister, R. J., & Graham, B. A. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02090-0 · Cited by 27
Neuropathic pain following spinal cord injury pain: mechanisms and treatment
Finnerup, N. B., Baastrup, C., & Jensen, T. S. (2009) · Scandinavian Journal of Pain · doi:10.1016/s1877-8860(09)70003-5 · Cited by 27
Physiology and Pharmacology of the GABA System: Focus on GABA Receptors
Möhler, H. (2010) · Springer eBooks · doi:10.1007/978-3-0346-0226-6_1 · Cited by 26
“Most importantly, in contrast to morphine, L-838417 failed to show tolerance in analgesic efficacy, as tested over a treatment period of 9 days [19].”
BackgroundInfluentialSelf-citationLu, V. B., Colmers, W. F., & Smith, P. A. (2012) · Journal of Neurophysiology · doi:10.1152/jn.00457.2011 · Cited by 21
“…of inhibitory synaptic transmission within the dorsal horn contributes to onset of central sensitization (Coull et al. 2005; Keller et al. 2007; Knabl et al. 2008; Prescott et al. 2006, 2008; Zeilhofer 2008; Zeilhofer et al. 2009) and administration of bicuculline and/or strychnine is known to…”
BackgroundTao, W., Chen, Q., Wang, L., Zhou, W., Wang, Y., & Zhang, Z. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.098186 · Cited by 22
Naderipoor, P., Amani, M., Abedi, A. J., Sakhaie, N., Sadegzadeh, F., & Saadati, H. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.01.006 · Cited by 20
Guerrini, G., Ciciani, G., Bruni, F., Selleri, S., Martini, C., Daniele, S., Ghelardini, C., Mannelli, L. D. C., & Costanzo, A. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.10.047 · Cited by 21
Pentameric Ligand-Gated Ion Channels as Pharmacological Targets Against Chronic Pain
Lara, C. O., Burgos, C. F., Moraga‐Cid, G., Carrasco, M. A., & Yévenes, G. E. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00167 · Cited by 22
“Other AEs associated with the use of opioids includes effects on the CNS such as delirium, reduced cognition, sedation, respiratory depression, tolerance, addiction, and physical dependence (Labianca et al., 2012).”
BackgroundInfluentialFischer, B. D., Teixeira, L. P., Linn, M. L. V., Namjoshi, O. A., Cook, J. M., & Rowlett, J. K. (2013) · Psychopharmacology · doi:10.1007/s00213-013-2975-2 · Cited by 20
“…receptors, respectively) are anatomically distributed in the cortex, limbic system and spinal cord, and have been associated with the anxiolytic and antihyperalgesic effects of benzodiazepines (McKernan et al., 2000; Löw et al., 2000; Rowlett et al., 2005, Fischer et al., 2010; Knabl et al., 2008).”
BackgroundChen, X., Li, Y., Xiao, J., Zhang, H., Yang, C., Wei, Z., Chen, W., Du, X., & Liu, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.565461 · Cited by 22
Acetazolamide attenuates chemical-stimulated but not thermal-stimulated acute pain in mice
Sun, Y., Chen, Y., Pang, C., Wu, N., & Li, J. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.149 · Cited by 19
Tashiro, A., Bereiter, D. A., Thompson, R., & Nishida, Y. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.11.053 · Cited by 20
Search for α3β2/3γ2 subtype selective ligands that are stable on human liver microsomes
Namjoshi, O. A., Wang, Z.-J., Rallapalli, S., Johnson, E. M., Johnson, Y.-T., Ng, H. H., Ramerstorfer, J., Varagić, Z., Sieghart, W., Majumder, S., et al. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.10.057 · Cited by 19
Role of GABAergic system in the comorbidity of pain and depression
Yang, S., Zhang, B., Wang, D., Hu, S.-W., Wang, W., Liu, C., Wu, Z., & Yang, C. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110691 · Cited by 20
Moerke, M. J., Li, G., Golani, L. K., Cook, J. M., & Negus, S. S. (2019) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000464 · Cited by 18
“, 2004) and rodents (Luger et al., 1995; Knabl et al., 2008) GABAAR PAMs are effective in producing analgesic effects when administered by the intrathecal route.”
Atack, J. R. (2010) · Springer eBooks · doi:10.1007/978-3-0346-0226-6_2 · Cited by 23
“Using this strategy, Mohler, Rudolph and colleagues plus, to a lesser extent, the group at Merck have begun to dissect which of the pharmacological features of diazepam in particular, but also certain other benzodiazepine site modulators, are associated with which specific subtypes of GABAA receptor [40–46].”
Inter-Strain Differences of Serotonergic Inhibitory Pain Control in Inbred Mice
Wijnvoord, N., Albuquerque, B., Häußler, A., Myrczek, T., Popp, L., & Tegeder, I. (2010) · Molecular Pain · doi:10.1186/1744-8069-6-70 · Cited by 19
“Conversely, nerve injury was associated with GABAergic dysinhibition [1,19].”
BackgroundNagasaka, K., Nemoto, K., Takashima, I., Bando, D., Matsuda, K., & Higo, N. (2021) · Cerebral Cortex · doi:10.1093/cercor/bhab098 · Cited by 18
Ion Channel Blockers for the Treatment of Neuropathic Pain
Colombo, E. V., Francisconi, S., Faravelli, L., Izzo, E., & Pevarello, P. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.19 · Cited by 20
The effects of estrogen on temporomandibular joint pain as influenced by trigeminal caudalis neurons
Tashiro, A., & Bereiter, D. A. (2020) · Journal of Oral Science · doi:10.2334/josnusd.19-0405 · Cited by 22
When is an analgesic not an analgesic?
Fitzgerald, M. (2009) · Pain · doi:10.1016/j.pain.2009.03.015 · Cited by 17
“It could be argued that a calmer baby is a physiologically more stable baby and that this is an important part of pain relief, but the neural mechanisms of sedation and analgesia are not the same [5].”
BackgroundLiu, P., Zhang, X., He, X., Jiang, Z., Wang, Q., & Lü, Y. (2021) · Molecular Pain · doi:10.1177/1744806921992620 · Cited by 20
Advances in the pharmacology of lGICs auxiliary subunits
Galaz, P., Barra, R., Figueroa, H., & Mariqueo, T. A. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.07.026 · Cited by 19
Inhibition of Activity of GABA Transporter GAT1 by δ -Opioid Receptor
Pu, L., Xu, N., Xia, P., Gu, Q., Ren, S., Fucke, T., Pei, G., & Schwarz, W. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/818451 · Cited by 16
“of chronic pain [8, 28], and regulation of GABA transportation has been shown to control pain sensation [11, 29].”
BackgroundChagraoui, A., Skiba, M., Thuillez, C., & Thibaut, F. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.08.001 · Cited by 19
“Furthermore, α4β2δ GABAARs, which lack a γ subunit, are not targeted by BZ agonists (Knoflach et al., 1996, Wafford et al., 1996).”
BackgroundObradović, A. L., Joksimovic, S. M., Poe, M. M., Ramerstorfer, J., Varagić, Z., Namjoshi, O. A., Batinić, B., Radulović, T., Marković, B. D., Roth, B. L., et al. (2014) · Brain Research · doi:10.1016/j.brainres.2014.01.036 · Cited by 18
“Genetic and pharmacological studies have focused on the role of benzodiazepines in central pain transmission on the population of α 2/3 GABA A receptors (Di Lio et al., 2011; Knabl et al., 2008).”
BackgroundThe role of spinal cord extrasynaptic α 5 GABA A receptors in chronic pain
Delgado‐Lezama, R., Bravo‐Hernández, M., Franco‐Enzástiga, Ú., la Luz-Cuellar, Y. E. D., Alvarado‐Cervantes, N. S., Raya‐Tafolla, G., Martínez‐Zaldivar, L. A., Vargas‐Parada, A., Rodríguez-Palma, E. J., Vidal‐Cantú, G. C., et al. (2021) · Physiological Reports · doi:10.14814/phy2.14984 · Cited by 23
“Extrasynaptic receptors mediate an alternative form of inhibition that modulates the neurons’ excitability by a persistent increase in conductance and tonic shunt (Brickley et al., 1996; Farrant & Nusser, 2005; Kullmann et al., 2005).”
BackgroundKim, Y. R., & Kim, S. J. (2022) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2022.26.2.69 · Cited by 18
“Previous studies on nociceptive pathways have suggested that alterations in inhibitory transmission are implicated in the development of chronic pain [10,30,31].”
BackgroundChen, S., Zang, Y., Zheng, W., Wei, X., & Liu, X. (2016) · The Chinese Journal of Physiology · doi:10.4077/cjp.2016.bad332 · Cited by 16
Neumann, E., Küpfer, L., & Zeilhofer, H. U. (2020) · Pain · doi:10.1097/j.pain.0000000000002030 · Cited by 15
“Facilitation of GABAergic inhibition in the spinal cord through benzodiazepine (BDZ) site ligands, which positively modulate GABAA receptor (GABAAR) function, reverses pathologically increased pain sensitivity (hyperalgesia) in rodent models of chronic inflammatory and neuropathic pain.(13) Work in genetically modifie…”
BackgroundMethodSelf-citationOxysophocarpine induces anti-nociception and increases the expression of GABAAα1 receptors in mice
Tingting, X., Li, Y., Wang, H., XU, Y., Ma, L., Sun, T., Ma, H., & Yu, J. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1414 · Cited by 17
Li, J., Zhang, L., Chu, X., Lin, Y., Zhang, Y., Wu, H., Chang, L., Zhang, Y., Luo, C., Li, F. Y., et al. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00883-w · Cited by 17
Ahrens, J., Leuwer, M., Demir, R., Krampfl, K., de la Roche, J., Foadi, N., Karst, M., & Haeseler, G. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0366-8 · Cited by 15
“…recent years, loss of inhibitory synaptic transmission within the dorsal horn of the spinal cord has been established as one of the major mechanisms involved in the development of chronic pain following inflammation or nerve injury (Bolay and Moskowitz 2002; Betz and Laube 2006; Knabl et al. 2008).”
BackgroundInfluentialJodoin, M., Rouleau, D. M., Bellemare, A., Provost, C., Larson-Dupuis, C., Sandman, É., Laflamme, G. Y., Benoit, B., Leduc, S., Levesque, M., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0226452 · Cited by 17
“A reduction of GABAergic inhibition has been shown to play a prominent role in chronic pain development and in pain maintenance [62].”
BackgroundXue, M., Liu, J. P., Yang, Y., Suo, Z., Yang, X. Z., & Hu, X. D. (2017) · European Journal of Pain · doi:10.1002/ejp.1009 · Cited by 16
“…in several animal models of patho- logical pain (Hwang and Yaksh, 1997; Kontinen and Dickenson, 2000; Malan et al., 2002; Gwak et al., 2006; Knabl et al., 2008; Munro et al., 2008, 2011; Ralvenius et al., 2015), although inconsistent results have also been obtained in some injury…”
BackgroundResultPape, J., Bertrand, S. S., Lafon, P., Odessa, M. F., Chaigniau, M., Stiles, J. K., & Garret, M. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.02.043 · Cited by 19
Besson, M. J., Daali, Y., Lio, A. D., Dayer, P., Zeilhofer, H. U., & Desmeules, J. A. (2012) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12017 · Cited by 16
Self-citationAnalgesic effect of clobazam in chronic low‐back pain but not in experimentally induced pain
Schliessbach, J., Vuilleumier, P. H., Siegenthaler, A., Bütikofer, L., Limacher, A., Jüni, P., Zeilhofer, H. U., Arendt‐Nielsen, L., & Curatolo, M. (2017) · European Journal of Pain · doi:10.1002/ejp.1032 · Cited by 15
Self-citationAgarwal, P., Misra, M., Sarkari, N. B. S., Gupta, A. K., & Agarwal, P. (1998) · PubMed · Cited by 16
Mortensen, D., Thoefner, M. S., Agerholm, J. S., Slumstrup, L., Jensen, T. S., Bjerrum, O. J., Berendt, M., & Nyengaard, J. R. (2022) · Pain · doi:10.1097/j.pain.0000000000002630 · Cited by 15
Electroacupuncture Suppresses CCI-Induced Neuropathic Pain through GABAA Receptors
Li, S., Jiang, X., Wu, Q., Jin, Y. H., He, R., Hu, J., & Zheng, Y. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/4505934 · Cited by 16
“In addition, it has been demonstrated that receptor α2 and α3 subunits play an important role in spinal cord antihyperalgesia induced by benzodiazepines [10].”
BackgroundHansen, R. R., Erichsen, H. K., Brown, D. T., Mirza, N. R., & Munro, G. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.08.002 · Cited by 14
Cruz‐Almeida, Y., Forbes, M. A., Cohen, R. C., Woods, A. J., Fillingim, R. B., Riley, J. L., & Porges, E. C. (2021) · PAIN Reports · doi:10.1097/pr9.0000000000000952 · Cited by 15
“Indeed, work in mice expressing genetically engineered GABAA receptor a subunits has shown that a2 and a3 GABAA receptors are themost relevantGABAA receptor subtypes for spinal analgesia.(27,44) Future studies are needed to replicate the sex by pain interactions in the GABAergic system in older adults.”
BackgroundResultRodríguez-Palma, E. J., la Luz-Cuellar, Y. E. D., Islas-Espinoza, A. M., Félix-Leyva, A. E., Shiers, S. I., García, G., Torres‐López, J. E., Delgado‐Lezama, R., Murbartián, J., Price, T. J., et al. (2022) · Pain · doi:10.1097/j.pain.0000000000002763 · Cited by 14
Suo, Z., Fan, Q., Yang, X. Z., & Hu, X. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23270 · Cited by 14
“GABAAR agonists have, therefore, been proposed as potent analgesics for pathological pain (Knabl et al., 2008).”
BackgroundWolz-Richter, S., Esser, K., & Hess, A. (2013) · Toxicon · doi:10.1016/j.toxicon.2013.07.019 · Cited by 14
Self-citationAnalgesic targets: today and tomorrow
Rodger, I. W. (2009) · Inflammopharmacology · doi:10.1007/s10787-009-0006-z · Cited by 13
Yamaoka, S., Oshima, Y., Horiuchi, H., Morino, T., Hino, M., Miura, H., & Ogata, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091962 · Cited by 14
“GABAA receptor agonists have, therefore, been proposed as potent analgesics for pathological pain [24].”
Chen, J., Li, H., Lim, G., McCabe, M. F., Zhao, W., Yang, Y., Ma, W.-Q., & Li, N. (2018) · IUBMB Life · doi:10.1002/iub.1713 · Cited by 13
“For example, Diazepam reversed pathological pain through specific spinal GABAA receptor subtypes a1, a2, and a3 (9).”
BackgroundEvolution of mirror-image pain in temporomandibular joint osteoarthritis mouse model
Rotpenpian, N., Tapechum, S., Vattarakorn, A., Chindasri, W., Care, C., Pakaprot, N., & Wanasuntronwong, A. (2021) · Journal of Applied Oral Science · doi:10.1590/1678-7757-2020-0575 · Cited by 13
GABAA receptors in GtoPdb v.2021.3
Belelli, D., Hales, T. G., Lambert, J. J., Lüscher, B., Olsen, R. W., Peters, J. A., Rudolph, U., & Sieghart, W. (2021) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f72/2021.3 · Cited by 17
Self-citationZhu, Y., Dua, S., & Gold, M. S. (2012) · Journal of Neurophysiology · doi:10.1152/jn.00590.2012 · Cited by 13
Spinal GABAA receptors for pain control: back to the future?
Zeilhofer, H. U., Neumann, E., & Munro, G. (2019) · British Journal of Anaesthesia · doi:10.1016/j.bja.2019.01.030 · Cited by 13
“Work in mice expressing genetically engineered GABAA receptor a subunits has shown that a2 (and a3) GABAA receptors are the most relevant GABAA receptor subtypes for spinal analgesia, and that a1 and a5 receptors contribute either nothing (a1) or very little (a5) to this process.(5,6) This profile fits well with the e…”
BackgroundSelf-citationLauria, P. S. S., Gomes, J. D. M., Abreu, L. S., Santana, R. C., Nunes, V. L. C., Couto, R. D., Colavolpe, P. O., da Silva, M. S., Soares, M. B. P., & Villarreal, C. F. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117710 · Cited by 14
Nascimento, G. C., Escobar-Espinal, D. M., Bálico, G. G., da Silva, N. R., & Del-Bel, E. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.04.016 · Cited by 15
Gene-based approaches in pain research and exploration of new therapeutic targets and strategies
Molet, J., & Pohl, M. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.073 · Cited by 16
Tolerance liability of diazepam is dependent on the dose used for protracted treatment
Divljaković, J., Milić, M., Stamenić, T. T., & Savić, M. M. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70908-8 · Cited by 12
New approaches to the pharmacotherapy of neuropathic pain
Besson, M. J., Piguet, V., Dayer, P., & Desmeules, J. A. (2008) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.1.5.683 · Cited by 13
Neuropathic Pain: Literature Review and Recommendations of Potential Phytotherapies
Raafat, K. M., El-Haj, R., Shoumar, D., Alaaeddine, R. A., Fakhro, Y., Tawil, N., Shaer, F., Daher, A., Awada, N., Sabra, A., et al. (2017) · Pharmacognosy Journal · doi:10.5530/pj.2017.4.72 · Cited by 12
Alonso, B. D. C., Sergeyeva, M., Brune, K., & Heß, A. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.05.045 · Cited by 12
“All experiments followed the same order of events: standard scanner setup, a motion control scan as previously described (Hess et al., 2007; Knabl et al., 2008) followed by the fMRI experiment and finally anatomical image acquisition. fMRI data was acquired with a Gradient-Echo Echo Planar Imaging…”
BackgroundMethodSelf-citationYan, L., Pan, M., Fu, M., Wang, J., Huang, W., & Qian, H. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.01.009 · Cited by 12
Protein complexes as psychiatric and neurological drug targets
Kato, A., & Witkin, J. M. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.01.018 · Cited by 13
“The antihyperalgesic action of intrathecal application of the DZ-site ligand, L-838,417, is reduced, in α2(H101R) mice [81].”
BackgroundDurkin, E., Muessig, L., Herlt, T., Lumb, M. J., Patel, R., Thomas, P., Bright, D. P., Jurd, R., Moss, S. J., Dickenson, A. H., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/462457 · Cited by 16
“Furthermore, a reduction in GABAAR mediated synaptic inhibition is important in the dorsal horn of the spinal cord for the development of pain, such that GABAARs are considered to be therapeutic targets for analgesic agents (Knabl et al., 2008; Zeilhofer et al., 2012).”
BackgroundLi, C., Chen, S., Yu, Y., Zhou, C., Wang, Y., Kang, L., Li, D., Shao, W., Lü, L., You, Y., et al. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8558-8 · Cited by 13
“Deficits in the functional expression of GABAARs contribute to several neuropsychiatric conditions including epilepsy [3, 4], anxiety and depression [5, 6], substance abuse [7], schizophrenia [6], and pain [8].”
Wernze, H., & Herdegen, T. (2014) · Scandinavian Journal of Pain · doi:10.1016/j.sjpain.2013.12.003 · Cited by 13
Javdani, F., Holló, K., Hegedűs, K., Kis, G. N., Hegyi, Z., Dócs, K., Kasugai, Y., Fukazawa, Y., Shigemoto, R., & Antal, M. (2015) · The Journal of Comparative Neurology · doi:10.1002/cne.23774 · Cited by 11
HEME: a neglected player in nociception?
Chiabrando, D., Fiorito, V., Petrillo, S., Bertino, F., & Tolosano, E. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.01.011 · Cited by 12
Juif, P., Melchior, M., & Poisbeau, P. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.12.022 · Cited by 12
“…of GABAAR agonists and of allosteric-positive GABAAR modulators have previously proven their efficacy to reduce pain thresholds in human and animal models (Clavier et al., 1992; Eaton et al., 1999; Edwards et al., 1990; Goodchild and Serrao, 1987; Knabl et al., 2008; Serrao et al., 1992).”
Upregulation of high-affinity GABAA receptors in cultured rat dorsal root ganglion neurons
Lee, K. Y., Charbonnet, M., & Gold, M. S. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.01.050 · Cited by 15
“Interestingly, benzodiazepines, thought o act at -subunit-containing synaptic receptors, were analgesic both in the presence and absence of tissue injury (Anseloni and Gold, 2008; Knabl et al., 2008).”
GABA and Sleep: Molecular, Functional and Clinical Aspects
Reite, M. L. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11010133 · Cited by 12
The Condition of Neuropathic Pain
Toth, C. C., & Moulin, D. E. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139152211.005 · Cited by 11
Gurrell, R., Whitlock, M., Wei, H., Shen, Z., & Ogden, A. G. (2021) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.912 · Cited by 11
Kitayama, T., Morita, K., Sultana, R., Kikushige, N., Mgita, K., Ueno, S., Hirata, M., & Kanematsu, T. (2013) · Molecular Pain · doi:10.1186/1744-8069-9-23 · Cited by 10
Gene sequencing for identification of Paragonimus eggs from a human case.
Chang, Z.-S., Wu, B., Blair, D., Zhang, Y. N., Hu, L., Chen, S. H., Chen, M. G., Feng, Z., & Davis, G. M. (2000) · PubMed · Cited by 16
Liu, J., He, Y., Duan, X.-L., Suo, Z., Yang, X. Z., & Hu, X. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.12.002 · Cited by 10
Alijanpour, S., Jafaripour, S., Ghasemzadeh, Z., Khakpai, F., & Zarrindast, M. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173806 · Cited by 9
Fischer, B. D., Platt, D. M., Rallapalli, S., Namjoshi, O. A., Cook, J. M., & Rowlett, J. K. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.10.026 · Cited by 10
“Subsequent reports have postulated that the diverse behavioral effects of benzodiazepine-type drugs may reflect actions at different subtypes of GABAA receptors (e.g., Knabl et al., 2008; Löw et al., 2000; McKernan et al., 2000; Rowlett et al., 2005; Rudolph et al., 1999; Tan et al., 2010).”
BackgroundDong, S., Hu, Y., Du, W., Tao, W., Zhang, X. H., Zhuang, P., & Li, Y. J. (2012) · Journal of International Medical Research · doi:10.1177/147323001204000429 · Cited by 9
Humble, S. R. (2016) · F1000Research · doi:10.12688/f1000research.9034.1 · Cited by 9
“Therefore, pharmacological agents that enhance GABA A R function could be useful to counteract lost inhibitory tone (Knabl et al., 2008; Munro et al., 2009).”
BackgroundRebuilding CNS inhibitory circuits to control chronic neuropathic pain and itch
Braz, J. M., Etlin, A., Juarez-Salinas, D. L., Llewellyn‐Smith, I. J., & Basbaum, A. I. (2017) · Progress in brain research · doi:10.1016/bs.pbr.2016.10.001 · Cited by 8
Tudeau, L., Acuña, M. A., Albisetti, G. W., Neumann, E., Ralvenius, W. T., Scheurer, L., Poe, M. M., Cook, J. M., Johannssen, H. C., & Zeilhofer, H. U. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146889 · Cited by 10
Self-citationRahman, M. A., Keck, T. M., Poe, M. M., Sharmin, D., Cook, J. M., & Fischer, B. D. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05791-1 · Cited by 12
Belardetti, F. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.30 · Cited by 10
Metadata
- Authors
- Knabl, J., Witschi, R., Hösl, K., Reinold, H., Zeilhofer, U. B., Ahmadi, S., Brockhaus, J., Sergejeva, M., Hess, A., Brune, K., Fritschy, J.-M., Rudolph, U., Möhler, H., & Zeilhofer, H. U.
- Affiliations
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- University of Zurich (CH)
- University of Bonn (DE)
- Harvard University (US)
- Corresponding author
- Zeilhofer, Hanns Ulrich
- Venue
- Nature
- Published
- 2008-01
- Volume
- 451
- Issue
- 7176
- Pages
- 330-334
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2011606970
- Cited by
- 438
- References
- 43
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 13 · 2023: 10 · 2022: 15 · 2021: 22 · 2020: 24 · 2019: 17 · 2018: 23 · 2017: 21 · 2016: 27 · 2015: 33 · 2014: 27 · 2013: 38 · 2012: 38
- FWCI
- 23.97
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Treatment
- Keywords
- chronic pain, neuropathic pain, inflammatory pain, GABAA receptor subtypes, alpha2 subunit, alpha3 subunit, synaptic inhibition, dorsal horn, GABAergic neurotransmission, knock-in mice, analgesia, sedation, tolerance (pharmacology and immunology), pain-related brain activity
- MeSH terms
- Analgesics, Animals, Brain, Capsaicin, Chronic Disease, Diazepam, Disease Models, Animal, Fluorobenzenes, Formaldehyde, Ganglia, Spinal, Hot Temperature, Inflammation, Male, Neurons, Organ Specificity, Pain, Receptors, GABA-A, Spinal Cord, Triazoles, Rats, Wistar, Protein Isoforms, Protein Subunits, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.